Sanofi says monitoring outcomes of ongoing dengue vaccination schemes
PARIS (Reuters) – Sanofi on Monday said it was monitoring outcomes of ongoing public programs involving its dengue vaccine, Dengvaxia, following the launch of a probe in the Philippines.